Reaction
Primary Myelofibrosis reporting signals
As of the last recalculation, Primary Myelofibrosis appears in 313 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is RUXOLITINIB (PRR 120.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ruxolitinib | 92 | 120.5 | 120.7 |
| Hydroxyurea | 32 | 112.0 | 112.1 |
| Oseltamivir | 6 | 51.1 | 51.1 |
| Azacitidine For | 13 | 49.5 | 49.6 |
| Deferasirox | 18 | 47.8 | 47.9 |
| Azacitidine | 14 | 32.8 | 32.8 |